Вы находитесь на странице: 1из 2

ACTION PLAN

Purpose: To purchase and use Chlorhexidince Gluconate as a substitute antiseptic agent for patients undergoing surgery and other kinds of procedures that require disinfection of the skin. Directions: 1. To present the result of the research in a personnel meeting. 2. To develop a core personnel (EBP Team) to facilitate the implementation of using Chlorhexidine Gluconate as a substitute antiseptic agent for patients undergoing surgery and other kinds of procedures that require disinfection of the skin. 3. To review the financial expenses/gain of the hospital in purchasing antiseptic solutions and the incidence rate of infections related to surgery and other kinds of procedures that require disinfection of the skin. 4. To have a pilot study for 2 months regarding the efficacy of using Chlorhexidine Gluconate and Povidine Iodine as an antiseptic solutions in reducing surgery-related and other procedure-acquired infections. 5. To compare the results of using Chlorhexidine Gluconate and Povidone Iodine in reducing surgery-related and other procedure-acquired infections, and from the previous data of infection incidence in the hospital. 6. To present the results of the study in a personnel meeting. Results/Accomplishments:
Action Steps What Will Be Done? Responsibilities Who Will Do It? Timeline By When? (Day/Month) 4th week of April, 2013 Resources A. Resources Available B. Resources Needed (financial, human, political & other) A. Lecture materials, venue, printed copies of the research B. Meeting time Step 2: Creation of Core-Personnel (EBP Team) 1Administrative Officer Physician 1Medical Technologist 3 Registered Nurses 1 Nurse Department Heads 4th week of April, 2013 A. Writing materials, venue, B. Holding effective selection process Potential Barriers A. What individuals or organizations might resist? B. How? A. Nurses, Physicians and other hospital personnel B. Reluctant to change and new ideas A. All hospital personnel B. Resistant to new obligation and responsibilities Communication Plan Who is involved? What methods? How often? All Department Heads and hospital personnel Lectures and forum

Step 1: Information dissemination

Researcher

All hospital personnel Voting/Selection Process

Attendant/Midwife 1st week of May, 2013

Step 3: Financial Study of Antiseptic Purchases and Incidence Rate of Infections (Hospital Records)

Audit Officer Core-Personnel (EBP Team)

A. Financial Reports, Hospital Records and other pertinent documents B. Reliable person for data computation

A. Budget Officer, Administrative Officer, Medical Records Department B. Incomplete papers or data for study, No records available

Chief of Hospital, Administrative Officer, Budget Officer and Head of Medical Records Communication Letters

Step 4: Pilot Study

Core-Personnel (EBP Team)

1st week of June, 2013 to 4th week of July, 2013

A. Povidone Iodine and other materials for disinfection, meeting time, process documentation B. Chlorhexidine Gluconate, participating personnel and patients

A. Subject Patients, some hospital personnel B. Hesitance

Chief of Hospital, Head of Medical Laboratory and Subject Patients Communication Letters and Consent Forms

Step 5: Review of Results

Core-Personnel (EBP Team)

1st week of August, 2013

A. Culture/Laboratory Data, Hospital Records B. Recording materials, reliable person for data computation

A. Core-Personnel B. Bulk of work (collection of data, analysis and interpretation)

Nursing Heads

Step 6: Presentation of Results

Core-Personnel (EBP Team)

3rd week of August, 2013

A. Lecture materials, venue, printed copies of the research B. Meeting time

A. Nurses, Physicians and other hospital personnel B. Reliability of results and collection and treatment of data

All Department Heads and hospital personnel Lectures and forum

Evidence Of Success (How will you know that you are making progress? What are your benchmarks?) 1. Reduction of surgery-related and other procedure-acquired infections in the hospital. 2. Decrease in financial expenses for antiseptic solution. 3. Improved confidence rate in using Chlorhexidine Gluconate as skin disinfectant in patients and hospital personnel. 4. Improved patient care through provision of research-based nursing and medical services.